[go: up one dir, main page]

ES2180449A1 - Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria. - Google Patents

Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Info

Publication number
ES2180449A1
ES2180449A1 ES200101587A ES200101587A ES2180449A1 ES 2180449 A1 ES2180449 A1 ES 2180449A1 ES 200101587 A ES200101587 A ES 200101587A ES 200101587 A ES200101587 A ES 200101587A ES 2180449 A1 ES2180449 A1 ES 2180449A1
Authority
ES
Spain
Prior art keywords
aryl
derivatives
treatment
urinary incontinence
heteroaril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200101587A
Other languages
English (en)
Other versions
ES2180449B1 (es
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to ES200101587A priority Critical patent/ES2180449B1/es
Priority to UA2004020880A priority patent/UA79238C2/uk
Priority to BR0211237-0A priority patent/BR0211237A/pt
Priority to DK02745440T priority patent/DK1413305T3/da
Priority to ES02745440T priority patent/ES2263792T3/es
Priority to PL02369062A priority patent/PL369062A1/xx
Priority to JP2003510033A priority patent/JP2004521150A/ja
Priority to AT02745440T priority patent/ATE327752T1/de
Priority to PCT/ES2002/000326 priority patent/WO2003004022A1/es
Priority to CA002452646A priority patent/CA2452646A1/en
Priority to DE60211913T priority patent/DE60211913T2/de
Priority to ARP020102482A priority patent/AR034679A1/es
Priority to NZ530817A priority patent/NZ530817A/en
Priority to CNA028161009A priority patent/CN1543344A/zh
Priority to EP02745440A priority patent/EP1413305B1/en
Priority to SI200230346T priority patent/SI1413305T1/sl
Priority to MXPA04000065A priority patent/MXPA04000065A/es
Priority to PT02745440T priority patent/PT1413305E/pt
Priority to RU2004103475/15A priority patent/RU2308268C2/ru
Priority to KR10-2004-7000056A priority patent/KR20040030788A/ko
Priority to US10/189,915 priority patent/US20030022925A1/en
Publication of ES2180449A1 publication Critical patent/ES2180449A1/es
Priority to NO20040031A priority patent/NO20040031L/no
Priority to US10/753,161 priority patent/US20040142929A1/en
Application granted granted Critical
Publication of ES2180449B1 publication Critical patent/ES2180449B1/es
Priority to ZA200400780A priority patent/ZA200400780B/en
Priority to MA27514A priority patent/MA27056A1/fr
Priority to US11/045,708 priority patent/US20050131049A1/en
Priority to CY20061101049T priority patent/CY1105113T1/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria. Los derivados de aril(o heteroaril) azolilcarbinoles de fórmula general (I), en la cual Ar representa un radical fenilo o un radical tienilo, opcionalmente sustituidos, R1 representa un átomo de hidrógeno o un grupo alquilo inferior, R2 representa un radical dialquilaminoalquilo o azaheterociclilalquil y Het representa un azol no sustituido u opcionalmente sustituido por uno o dos sustituyentes, así como sus sales fisiológicamente aceptables; son útiles como medicamentos en terapéutica humana y/o veterinaria para el tratamiento de la incontinencia urinaria, en mamíferos, incluido el hombre.
ES200101587A 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria. Expired - Fee Related ES2180449B1 (es)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
UA2004020880A UA79238C2 (en) 2001-07-06 2002-01-07 Use of derivatives of aryl (or heteroaryl) azolylcarbinoles
MXPA04000065A MXPA04000065A (es) 2001-07-06 2002-07-01 Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria.
ES02745440T ES2263792T3 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
PL02369062A PL369062A1 (en) 2001-07-06 2002-07-01 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
JP2003510033A JP2004521150A (ja) 2001-07-06 2002-07-01 尿失禁治療用アリール（またはヘテロアリール）アゾリルカルビノール誘導体
AT02745440T ATE327752T1 (de) 2001-07-06 2002-07-01 Aryl- (oder heteroaryl-) azolylcarbynolderivatve zur behandlung von harninkontinenz
PCT/ES2002/000326 WO2003004022A1 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria
CA002452646A CA2452646A1 (en) 2001-07-06 2002-07-01 Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatement ofurinary incontinence
DE60211913T DE60211913T2 (de) 2001-07-06 2002-07-01 Aryl- (oder heteroaryl-) azolylcarbynolderivatve zur behandlung von harninkontinenz
ARP020102482A AR034679A1 (es) 2001-07-06 2002-07-01 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria
NZ530817A NZ530817A (en) 2001-07-06 2002-07-01 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
CNA028161009A CN1543344A (zh) 2001-07-06 2002-07-01 治疗尿失禁的芳基(或杂芳基)氮杂茂甲醇衍生物
EP02745440A EP1413305B1 (en) 2001-07-06 2002-07-01 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
BR0211237-0A BR0211237A (pt) 2001-07-06 2002-07-01 Uso de derivados de aril (ou heteroaril) azolil-carbinóis para o tratamento de incontinência urinária e composição farmacêutica
SI200230346T SI1413305T1 (sl) 2001-07-06 2002-07-01 Aril (ali heteroaril) azolikarbonil derivati za zdravljenje urinske inkontinence
PT02745440T PT1413305E (pt) 2001-07-06 2002-07-01 Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria
DK02745440T DK1413305T3 (da) 2001-07-06 2002-07-01 Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens
KR10-2004-7000056A KR20040030788A (ko) 2001-07-06 2002-07-01 요실금 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체
RU2004103475/15A RU2308268C2 (ru) 2001-07-06 2002-07-01 Производные арил- или гетероарилазолилкарбинолов для лечения недержания мочи
US10/189,915 US20030022925A1 (en) 2001-07-06 2002-07-03 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
NO20040031A NO20040031L (no) 2001-07-06 2004-01-05 Aryl-(eller heteroaryl)azolylkarbynolderivater for behandlingen av urininkontinens
US10/753,161 US20040142929A1 (en) 2001-07-06 2004-01-06 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
ZA200400780A ZA200400780B (en) 2001-07-06 2004-01-30 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence.
MA27514A MA27056A1 (fr) 2001-07-06 2004-02-04 Derives d'azolylcarbinols d'aryle (ou d'heteroaryle) pour le traitement de l'incontinence d'urine.
US11/045,708 US20050131049A1 (en) 2001-07-06 2005-01-28 Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
CY20061101049T CY1105113T1 (el) 2001-07-06 2006-07-28 Παραγωγα της αρυλικης (ή ετepοαρυλικης) αζολυλκαρβυνολης για την αντιμετωπιση της ακρατειας ουρων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Publications (2)

Publication Number Publication Date
ES2180449A1 true ES2180449A1 (es) 2003-02-01
ES2180449B1 ES2180449B1 (es) 2004-01-16

Family

ID=8498326

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200101587A Expired - Fee Related ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
ES02745440T Expired - Lifetime ES2263792T3 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02745440T Expired - Lifetime ES2263792T3 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Country Status (23)

Country Link
US (2) US20030022925A1 (es)
EP (1) EP1413305B1 (es)
JP (1) JP2004521150A (es)
KR (1) KR20040030788A (es)
CN (1) CN1543344A (es)
AR (1) AR034679A1 (es)
AT (1) ATE327752T1 (es)
BR (1) BR0211237A (es)
CA (1) CA2452646A1 (es)
CY (1) CY1105113T1 (es)
DE (1) DE60211913T2 (es)
DK (1) DK1413305T3 (es)
ES (2) ES2180449B1 (es)
MA (1) MA27056A1 (es)
MX (1) MXPA04000065A (es)
NO (1) NO20040031L (es)
NZ (1) NZ530817A (es)
PL (1) PL369062A1 (es)
PT (1) PT1413305E (es)
RU (1) RU2308268C2 (es)
UA (1) UA79238C2 (es)
WO (1) WO2003004022A1 (es)
ZA (1) ZA200400780B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070021485A1 (en) * 2005-07-22 2007-01-25 Gomis Antonio F Aryl (or heteroaryl) azolylcarbinols
ES2334548B1 (es) * 2005-07-29 2010-10-27 Laboratorios Del Dr. Esteve, S.A Forma de dosificacion de liberacion controlada de compuestos de pirazol para el tratamiento de la incontinencia urinaria.
US8722079B2 (en) 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
WO2010123999A2 (en) * 2009-04-21 2010-10-28 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416894A (en) * 1981-01-30 1983-11-22 Sandoz Ltd. Organic compounds
ES2137136A1 (es) * 1998-05-18 1999-12-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378A1 (es) * 1998-08-07 2000-11-16 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
ES2150353A1 (es) * 1998-04-15 2000-11-16 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416894A (en) * 1981-01-30 1983-11-22 Sandoz Ltd. Organic compounds
ES2150353A1 (es) * 1998-04-15 2000-11-16 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136A1 (es) * 1998-05-18 1999-12-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378A1 (es) * 1998-08-07 2000-11-16 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
PL369062A1 (en) 2005-04-18
AR034679A1 (es) 2004-03-03
CN1543344A (zh) 2004-11-03
DK1413305T3 (da) 2006-09-18
PT1413305E (pt) 2006-09-29
DE60211913D1 (de) 2006-07-06
DE60211913T2 (de) 2007-05-24
RU2004103475A (ru) 2005-06-10
WO2003004022A1 (es) 2003-01-16
EP1413305B1 (en) 2006-05-31
MA27056A1 (fr) 2004-12-20
ATE327752T1 (de) 2006-06-15
KR20040030788A (ko) 2004-04-09
NZ530817A (en) 2005-07-29
ES2180449B1 (es) 2004-01-16
BR0211237A (pt) 2004-08-10
US20050131049A1 (en) 2005-06-16
CY1105113T1 (el) 2010-03-03
JP2004521150A (ja) 2004-07-15
RU2308268C2 (ru) 2007-10-20
NO20040031L (no) 2004-03-02
UA79238C2 (en) 2007-06-11
MXPA04000065A (es) 2004-05-21
ZA200400780B (en) 2005-01-31
US20030022925A1 (en) 2003-01-30
CA2452646A1 (en) 2003-01-16
ES2263792T3 (es) 2006-12-16
EP1413305A1 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
ES2180449A1 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
ES2314418T3 (es) Derivados de amidas del acido 4-bromo-5-(2-clorobenzoilamino)-1h-pirazol-3-carboxicilico y compuestos relacionados como antagonistas del receptor b1 de bradiquinina para el tratamiento de enfermedades inflamatorias.
CY1110149T1 (el) Ειδικη ενωση γλυκοκορτικοστεροειδους που εχει αντιφλεγμονωδη δραστικοτητα
CY1117132T1 (el) Παραγωγο θειαζολιου
ECSP10010014A (es) Derivados de 2-alquiltio-2-quinoliniloxi-acetamida como fungicidas
ECSP088829A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1 (cb1)
DE602004022404D1 (de) 4-anilino-chinazolin-derivate als proliferationshemmende mittel
CO6341631A2 (es) Derivados de 1,2,4 - oxadiazol y su uso terapéutico
GEP20156267B (en) 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
MX2010001170A (es) Derivados de imidazolona, metodo de preparacion de los mismos y uso biologico de los mismos.
DE602005014341D1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
CL2024000297A1 (es) Derivados de pirazol microbiocidas.
SE0402762D0 (sv) Indazole sulphonamide derivatives
UY34426A (es) Derivados de heteroarilcarboxamida, procesos de preparación, composiciones y sus usos en agricultura, veterinaria y control de plagas
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
CL2024001758A1 (es) Derivados heterocíclicos bicíclicos microbiocidas.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
CY1111848T1 (el) Υποκατεστημενες πιπεραζινυλο πυραζινες kai πυριδινες ως ανταγωνιστες του 5-ht7 υποδοχεα
CO2025010537A2 (es) Derivados de pirazol microbiocidas
UY29709A1 (es) "compuestos quimicos"
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
TW200613297A (en) Pyrazole derivatives
CY1108371T1 (el) 1-φαινυλ και 1-πυριδυλπυραζολιου παραγωγα και χρηση αυτων ως ζιζανιοκτονα
ES2174756A1 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030201

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2180449B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807